Literature DB >> 19478259

Utility of a protein fraction with cathepsin L-Like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosis.

Mirko Zimic1, Mónica Pajuelo, Daniel Rueda, César López, Yanina Arana, Yesenia Castillo, Maritza Calderón, Silvia Rodriguez, Patricia Sheen, Joseph M Vinetz, Armando Gonzales, Héctor H García, Robert H Gilman.   

Abstract

Neurocysticercosis, an endemic parasitic disease in most developing countries, is caused by Taenia solium and compromises the human central nervous system. Cathepsin L-like proteases are secreted by several parasites including T. solium and constitute important antigens for immunodiagnostics. A protein fraction with cathepsin L-like activity was purified from the cysticercus fluid by size exclusion and ion exchange chromatography. Cathepsin L-like activity was measured fluorometrically by detecting the hydrolysis of the fluorogenic substrate Z-Phe-Arg-AMC. The purified protein fraction included antigens of 53 and 25 kD that were tested in a Western immunoblot and in an enzyme-linked immunosorbent assay (ELISA) for detection of human cysticercosis. The sensitivity of the Western immunoblot was 96% for patients infected with multiple cysts and 78% for patients with a single cyst. Specificity was 98%. The sensitivity of the ELISA was 98% in patients with multiple cysts and 84% in patients with a single cyst. Specificity was 92.7%.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478259      PMCID: PMC2762273     

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  33 in total

1.  Application of synthetic peptides to the diagnosis of neurocysticercosis.

Authors:  Agnès Fleury; Constantino Beltran; Elizabeth Ferrer; Terésa Garate; Leslie J S Harrison; R Michael E Parkhouse; Esperanza Garcia; Gladis Fragoso; Julia Costa-Cruz; Germano Biondi; Svetlana Agapejev; Edda Sciutto
Journal:  Trop Med Int Health       Date:  2003-12       Impact factor: 2.622

2.  Characterization of excretory/secretory endopeptidase and metallo-aminopeptidases from Taenia crassiceps metacestodes.

Authors:  Salman Baig; Raymond T Damian; Jorge Morales-Montor; Paula Olecki; Jamil Talhouk; Rayhan Hashmey; A Clinton White
Journal:  J Parasitol       Date:  2005-10       Impact factor: 1.276

3.  Identification and characterization of a cathepsin L-like cysteine protease from Taenia solium metacestode.

Authors:  Ai Hua Li; Sung-Ung Moon; Yun-Kyu Park; Byoung-Kuk Na; Myung-Gi Hwang; Chang-Mi Oh; Shin-Hyeong Cho; Yoon Kong; Tong-Soo Kim; Pyung-Rim Chung
Journal:  Vet Parasitol       Date:  2006-07-25       Impact factor: 2.738

4.  Cysticercosis immunodiagnosis using 18- and 14-kilodalton proteins from Taenia crassiceps cysticercus antigens obtained by immunoaffinity chromatography.

Authors:  Noeli Maria Espíndola; Alberto Hiroshi Iha; Irene Fernandes; Osvaldo Massaiti Takayanagui; Luís Dos Ramos Machado; José Antônio Livramento; Antônio Augusto Mendes Maia; José Mauro Peralta; Adelaide José Vaz
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Use of a pre-selected epitope of cathepsin-L1 in a highly specific peptide-based immunoassay for the diagnosis of Fasciola hepatica infections in cattle.

Authors:  J B Cornelissen; C P Gaasenbeek; W Boersma; F H Borgsteede; F J van Milligen
Journal:  Int J Parasitol       Date:  1999-05       Impact factor: 3.981

6.  Serodiagnosis of neurocysticercosis using synthetic 8-kD proteins: comparison of assay formats.

Authors:  Christina M Scheel; Azra Khan; Kathy Hancock; Hector H Garcia; Armando E Gonzalez; Robert H Gilman; Victor C W Tsang
Journal:  Am J Trop Med Hyg       Date:  2005-10       Impact factor: 2.345

7.  Characterization of cysteine proteases from the carcinogenic liver fluke, Opisthorchis viverrini.

Authors:  Natthawut Kaewpitoon; Thewarach Laha; Sasithorn Kaewkes; Puangrat Yongvanit; Paul J Brindley; Alex Loukas; Banchob Sripa
Journal:  Parasitol Res       Date:  2007-12-19       Impact factor: 2.289

8.  Comparison of the peptidase activity in the oncosphere excretory/secretory products of Taenia solium and Taenia saginata.

Authors:  Mirko J Zimic; Jesús Infantes; César López; Jeanette Velásquez; Marilú Farfán; Mónica Pajuelo; Patricia Sheen; Manuela Verastegui; Armando Gonzalez; Hector H Garciá; Robert H Gilman
Journal:  J Parasitol       Date:  2007-08       Impact factor: 1.276

9.  Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis.

Authors:  Kathy Hancock; Azra Khan; Fatima B Williams; Melinda L Yushak; Sowmya Pattabhi; John Noh; Victor C W Tsang
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Recent Developments in the Epidemiology, Diagnosis, Treatment, and Prevention of Neurocysticercosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.663

View more
  9 in total

1.  The highly antigenic 53/25 kDa Taenia solium protein fraction with cathepsin-L like activity is present in the oncosphere/cysticercus and induces non-protective IgG antibodies in pigs.

Authors:  Mirko Zimic; Mónica Pajuelo; Robert H Gilman; Andrés H Gutiérrez; Luis D Rueda; Myra Flores; Nancy Chile; Manuela Verástegui; Armando Gonzalez; Héctor H García; Patricia Sheen
Journal:  Vet Immunol Immunopathol       Date:  2011-11-11       Impact factor: 2.046

2.  A dot-ELISA using a partially purified cathepsin-L-like protein fraction from Taenia solium cysticerci, for the diagnosis of human neurocysticercosis.

Authors:  R Piña; A H Gutiérrez; R H Gilman; D Rueda; C Sifuentes; M Flores; P Sheen; S Rodriguez; H H García; M Zimic
Journal:  Ann Trop Med Parasitol       Date:  2011-06

3.  Characterization of a novel cathepsin L-like protease from Taenia solium metacestodes for the immunodiagnosis of porcine cysticercosis.

Authors:  Nancy León-Janampa; Ruddy Liendo; Robert H Gilman; Carlos Padilla; Hector H García; Armando Gonzales; Patricia Sheen; Mónica J Pajuelo; Mirko Zimic
Journal:  Vet Parasitol       Date:  2019-01-29       Impact factor: 2.738

4.  TsAg5, a Taenia solium cysticercus protein with a marginal trypsin-like activity in the diagnosis of human neurocysticercosis.

Authors:  Analiz Rueda; Cecilia Sifuentes; Robert H Gilman; Andrés H Gutiérrez; Ruby Piña; Nancy Chile; Sebastián Carrasco; Sandra Larson; Holger Mayta; Manuela Verástegui; Silvia Rodriguez; Marcel Gutiérrez-Correa; Héctor H García; Patricia Sheen; Mirko Zimic
Journal:  Mol Biochem Parasitol       Date:  2011-08-26       Impact factor: 1.759

Review 5.  Immunological and molecular diagnosis of cysticercosis.

Authors:  Silvia Rodriguez; Patricia Wilkins; Pierre Dorny
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

6.  Genome analysis of Excretory/Secretory proteins in Taenia solium reveals their Abundance of Antigenic Regions (AAR).

Authors:  Sandra Gomez; Laura Adalid-Peralta; Hector Palafox-Fonseca; Vito Adrian Cantu-Robles; Xavier Soberón; Edda Sciutto; Gladis Fragoso; Raúl J Bobes; Juan P Laclette; Luis del Pozo Yauner; Adrián Ochoa-Leyva
Journal:  Sci Rep       Date:  2015-05-19       Impact factor: 4.379

7.  The immunological characteristics and probiotic function of recombinant Bacillus subtilis spore expressing Clonorchis sinensis cysteine protease.

Authors:  Zeli Tang; Mei Shang; Tingjin Chen; Pengli Ren; Hengchang Sun; Hongling Qu; Zhipeng Lin; Lina Zhou; Jinyun Yu; Hongye Jiang; Xinyi Zhou; Xuerong Li; Yan Huang; Jin Xu; Xinbing Yu
Journal:  Parasit Vectors       Date:  2016-12-19       Impact factor: 3.876

8.  Novel CRISPR-based detection of Leishmania species.

Authors:  Eva Dueñas; Jose A Nakamoto; Luis Cabrera-Sosa; Percy Huaihua; María Cruz; Jorge Arévalo; Pohl Milón; Vanessa Adaui
Journal:  Front Microbiol       Date:  2022-09-15       Impact factor: 6.064

9.  Cysticercus cellulosae antigens in the serodiagnosis of neurocysticercosis.

Authors:  Subhash Chandra Parija; Ar Gireesh
Journal:  Trop Parasitol       Date:  2011-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.